Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury von Saykally, Jessica N., Hatic, Haris, Keeley, Kristen L., Jain, Subhash C., Ravindranath, Vijayalakshmi, Citron, Bruce A.

Volltext

Factors affecting outcomes in gallbladder cancer: A single institution retrospective analysis von Hatic, Haris, Li, Peng, Paluri, Ravi Kumar

Volltext

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma von Shah, Harsh, Vardell, Victoria, Zacholski, Erin, Fegley, Amanda, Fedak, Kalub, Sundaram, Suchitra, Rajeeve, Sridevi, Goyal, Gaurav, Hatic, Haris, Torka, Pallawi, Ba Aqeel, Sheeba, Borogovac, Azra, Macdougall, Kira, Kothari, Shalin, Kress, Anna, Modi, Dipenkumar, Travers, Elizabeth, Chilakamarri, Nitin, Brem, Elizabeth, Stephens, Deborah M., Hu, Boyu, Fitzgerlad, Lindsey, Wagner, Charlotte, Ermann, Daniel

Volltext

Immune checkpoint inhibitors in lymphoma: challenges and opportunities von Hatic, Haris, Sampat, Devi, Goyal, Gaurav

Volltext

Clinical outcomes in COVID-19 patients with cancer who are treated with chemo- or immunotherapy von Hatic, Haris, Jung, Jenny B, Hearld, Kristine Ria, Deshane, Jessy, Das, Devika Govind

Volltext

Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse von Barlow, Brett, Hatic, Haris, Bodine, Charles Douglas, Mehta, Amitkumar, Goyal, Gaurav, Narkhede, Mayur

Volltext

Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy von Hatic, Haris, Hearld, Kristine R, Das, Devika, Deshane, Jessy

Volltext

Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis von Paluri, Ravi Kumar, Haris, Hatic, Li, Peng, Gbolahan, Olumide, Jacob, Rojymon, Manne, Upender

Volltext

Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM) von Hatic, Haris, Inselman, Shealeigh, Inselman, Jonathan, Kommalapati, Anuhya, Tella, Sri Harsha, Paludo, Jonas, Durani, Urshila, Go, Ronald S., Goyal, Gaurav

Volltext

Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy von Desai, Sanjal H., Sumransub, Nuttavut, Evans, Rich, Watkins, Marcus P, Karmali, Reem, Goyal, Gaurav, Hughes, Mitchell E., Khurana, Arushi, Hernandez-Ilizaliturri, Francisco J., Zurko, Joanna, Hassan, Ayesha, Hatic, Haris, Nizamuddin, Imran A., Evens, Andrew M, Anampa-Guzmán, Andrea Carolina, Lin, Yi, Isufi, Iris, Hamadani, Mehdi, Rajguru, Saurabh A, Lall, Naveena, Tun, Aung M., Hill, Brian T., Stephens, Deborah M., Caimi, Paolo F., Ermann, Daniel A., Kahl, Brad S., Landsburg, Daniel J., Nowakowski, Grzegorz S.

Volltext

Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort von Desai, Sanjal H, Watkins, Marcus P., Karmali, Reem, Goyal, Gaurav, Hughes, Mitchell, Khurana, Arushi, Hernandez-Ilizaliturri, Francisco, Sumransub, Nuttavut, Zurko, Joanna, Nizamuddin, Imran A., Hatic, Haris, Landsburg, Daniel A, Anampa-Guzman, Andrea, Hamadani, Mehdi, Lin, Yi, Isufi, Iris, Tun, Aung M, Hill, Brian T., Stephens, Deborah M., Caimi, Paolo F, Ermann, Daniel A., Kahl, Brad S., Nowakowski, Grzegorz S.

Volltext

Real-world outcomes of brentuximab vedotin maintenance after autologous stem cell transplant in relapsed/refractory classical Hodgkin lymphoma: Is less enough? von Wagner, Charlotte Burton, Ermann, Daniel Arthur, Boucher, Kenneth M., Nedved, Adrienne, Micallef, Ivana N. M., Hatic, Haris, Goyal, Gaurav, Hickey, Erin, Fegley, Amanda, Samuels, Courtney, Kamdar, Manali K., Ba Aqeel, Sheeba Habeeb, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Fedak, Kalub, Travers, Elizabeth, Shah, Harsh

Volltext

Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents von Desai, Sanjal, Spinner, Michael Alexander, David, Kevin A., Bachanova, Veronika, Goyal, Gaurav, Saba, Raya, Dorritie, Kathleen Anne, Azzi, Jacques Mario, Harris, Elyse, Fusco, Brendon, Sumransub, Nuttavut, Hatic, Haris, Ibrahim, Uroosa, Iyengar, Siddharth, Rappazzo, Katherine Cynthia, Baidoun, Firas, Orellana-Noia, Victor Manuel, Magid Diefenbach, Catherine S., Advani, Ranjana H., Micallef, Ivana N. M.

Volltext

Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Eff... von Wagner, Charlotte B, Ermann, Daniel A., Boucher, Ken, Nedved, Adrienne N., Micallef, Ivana N., Desai, Sanjal H, Hatic, Haris, Goyal, Gaurav, Zacholski, Erin, Fegley, Amanda, Sigmund, Audrey M., Bond, David A., Samuels, Courtney, Kamdar, Manali K., Ba Aqeel, Sheeba, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Sundaram, Suchitra, Fedak, Kalub, Modi, Dipenkumar, Travers, Elizabeth, Ayyappan, Sabarish, Chilakamarri, Nitin, Brem, Elizabeth A, Stephens, Deborah M., Hu, Boyu, Fitzgerald, Lindsey A., Shah, Harsh

Volltext

Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma von Desai, Sanjal H., Spinner, Michael A., David, Kevin, Bachanova, Veronika, Goyal, Gaurav, Kahl, Brad, Dorritie, Kathleen, Azzi, Jacques, Kenkre, Vaishalee P., Arai, Sally, Chang, Cheryl, Fusco, Brendon, Sumransub, Nuttavut, Hatic, Haris, Saba, Raya, Ibrahim, Uroosa, Harris, Elyse I., Shah, Harsh, Murphy, Jacob, Ansell, Stephen, Jagadish, Deepa, Orellana‐noia, Victor, Diefenbach, Catherine, Iyenger, Siddharth, Rappazzo, K. C., Mishra, Rahul, Choi, Yun, Nowakowski, Grzegorz S., Advani, Ranjana H., Micallef, Ivana N.

Volltext

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outc... von Wagner, Charlotte B., Boucher, Ken, Nedved, Adrienne, Micallef, Ivana N., Desai, Sanjal, Hatic, Haris, Goyal, Gaurav, Zacholski, Erin, Fegley, Amanda, Sigmund, Audrey M., Bond, David A., Samuels, Courtney, Kamdar, Manali K., Ba Aqeel, Sheeba, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Sundaram, Suchitra, Fedak, Kalub, Modi, Dipenkumar, Travers, Elizabeth, Ayyappan, Sabarish, Chilakamarri, Nitin, Brem, Elizabeth A., Ermann, Daniel A., Fitzgerald, Lindsey A., Hu, Boyu, Stephens, Deborah M., Shah, Harsh

Volltext

Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non–small Cell Lung Cancer von Schneider, Craig S., Hatic, Haris, Das, Devika, Cardan, Rex A., Stahl, John M., Bonner, James A., Kole, Adam J.

Volltext

Extract Protects Model Neurons from Traumatic Injury von Jessica N. Saykally, Haris Hatic, Kristen L. Keeley, Subhash C. Jain, Vijayalakshmi Ravindranath, Bruce A. Citron

Volltext

The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience von Manne, Ashish, Hatic, Haris, Li, Peng, Jacob, Rojymon, Williams, Grant, Paluri, Ravi

Volltext

Modulation of transcription factor Nrf2 in an in vitro model of traumatic brain injury von Hatic, Haris, Kane, Michael J, Saykally, Jessica N, Citron, Bruce A

Volltext